Active specific immunotherapy of advanced renal-cell carcinoma.

@article{Tykk1978ActiveSI,
  title={Active specific immunotherapy of advanced renal-cell carcinoma.},
  author={Heikki Tykk{\"a} and K J Oravisto and Timo Lehtonen and Seppo S Sarna and TH. TALLBERG},
  journal={European urology},
  year={1978},
  volume={4 4},
  pages={250-8}
}
The results of a specific active immunotherapy method following palliative nephrectomy in 31 patients suffering from advanced renal-cell carcinoma are presented. The control patient group comprised of 23 comparable cases, who did not receive immunotherapy. The minimum follow-up time for any patient is 4 years. The statistical 5-year survival rate of the immunotherapy group is 23.6% (SE = 7.8). 7 patients are still alive. The 5-year survival rate of the control group is 4.3% (SE = 4.3), without… CONTINUE READING